Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PROKR1 contributors: mct/npt - updated : 07-07-2020
HGNC name prokineticin receptor 1
HGNC id 4524
Location 2p13.3      Physical location : 68.872.953 - 68.882.706
Synonym name
  • G protein-coupled receptor 73
  • G-protein coupled receptor ZAQ
  • Synonym symbol(s) ZAQ, PKR1, GPR73a, PK-R1, GPR73,
    DNA
    TYPE functioning gene
    STRUCTURE 14.67 kb     2 Exon(s)
    MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    3 - 4287 44 393 - 2015 26574895
    EXPRESSION
    Type widely
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Cardiovascularheart   highly
    Digestiveliver   lowly
    Endocrinepancreas   highly
    Nervousbrainhindbrainmedulla oblongata lowly
    Reproductivefemale systemplacenta  highly Homo sapiens
     male systemtestis   
    Respiratorylung   lowly
    Skin/Tegumentskin    
    Urinarykidney   lowly
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Muscularstriatumskeletal  
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
    seven transmembrane segments
    HOMOLOGY
    interspecies homolog to murine Gpr73
    Homologene
    FAMILY
  • G protein coupled receptor family 1
  • CATEGORY receptor membrane G
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,cytoskeleton,microtubule
    text
  • PROKR1 was detected in primary cilia
  • basic FUNCTION
  • involved in G-protein coupled receptor protein signaling pathway
  • (PROK1) signalling via prokineticin receptor 1 (PROKR1) regulates the expression of several genes with important roles in endometrial receptivity and implantation.
  • PROKR1, but also PROKR2 might mediate a complementary signalling to the RET/GDNF pathway supporting proliferation/survival and differentiation of precursor cells during enteric nervous system (ENS) development
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    PROK1-PROKR1 signalling pathway regulating IL11
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein PROK1-PROKR1 interaction induced inositol phosphate mobilization and sequential phosphorylation of c-Src, epidermal growth factor receptor, and ERK 1/2 (Evans 2008)
  • PROK2-induced the formation of vessel-like structures by aortic endothelial cells expressing only PROKR1, and disorganized the tight junctions in hepatic sinusoidal endothelial cells expressing only PROKR2, confirming the divergent roles of these receptors
  • MRAP2 interacts with and inhibits the trafficking and signaling of the prokineticin receptor 1 (PROKR1)
  • TBX20 is a novel transcription factor regulating angiogenesis through the PROK2-PROKR1 (prokineticin receptor 1) pathway in both development and disease
  • PROK1 and PROK2 bind to two highly related G protein-coupled receptors (GPCRs), prokineticin receptor 1 (PROKR1) and prokineticin receptor 2 (PROKR2)
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --over  
    PROK1 and PROKR1 expression is elevated in decidua during early pregnancy and that PROK1-PROKR1 interaction regulates expression of a host of implantation-related genes (Evans 2008)
    Susceptibility to recurrent miscarriage (RM)
    Variant & Polymorphism other
  • PROKR1 (I379V) variant conferred lower risk for RM and may play protective roles in early pregnancy by altering calcium signaling and facilitating cell invasiveness
  • Candidate gene
    Marker
    Therapy target may represent a novel therapeutic target to limit myocardial injury following ischemic events (Urayama 2007)
    ANIMAL & CELL MODELS